Tan Dongmei, Zhou Chao, Han Sai, Hou Xuetao, Kang Shufang, Zhang Youzhong
Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China.
Department of Obstetrics and Gynecology, Laiwu Maternal and Child Health Care Hospital, Laiwu, Shandong 271100, P.R. China.
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13366. Epub 2024 Oct 18.
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, for the cell migration and invasion assay experiments shown in Fig. 2 on p. 6322, the 'HeLa/miR‑378 inhibitor' panels in Fig. 2B and C appeared to contain overlapping sections of data, such that these data panels were apparently derived from the same original source to show the results of purportedly different experiments. The authors have re‑examined their original data, and realize that Fig. 2C was inadvertently assembled incorrectly. The revised version of Fig. 2, now containing the correct data for the 'HeLa/miR‑378 inhibitor' experiment in Fig. 2C, is shown on the next page. Note that this error did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 17: 6319‑6326, 2018; DOI: 10.3892/mmr.2018.8645].
在上述论文发表之后,一位感兴趣的读者提请作者注意,对于第6322页图2所示的细胞迁移和侵袭试验实验,图2B和C中的“HeLa/miR-378抑制剂”组似乎包含重叠的数据部分,以至于这些数据组显然来自同一原始来源,以显示据称不同实验的结果。作者重新检查了他们的原始数据,意识到图2C被无意中错误组装。下一页展示了图2的修订版,现在图2C中包含“HeLa/miR-378抑制剂”实验的正确数据。请注意,此错误并未对本研究报告的结果或总体结论产生不利影响。所有作者都同意发表这份勘误表,并感谢《分子医学报告》的编辑给予他们发表此勘误表的机会。他们也希望就所造成的任何不便向该期刊的读者道歉。[《分子医学报告》17: 6319-6326, 2018; DOI: 10.3892/mmr.2018.8645]